Showing posts with label TGFß1 mRNA. Show all posts
Showing posts with label TGFß1 mRNA. Show all posts
Friday, January 21, 2011
Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin
Abstract ....... It is suggested that TGFß1 mRNA expression is an indicator of tumor sensitivity to standard therapy with PTX (Taxol) and CBDCA (Carboplatin), that it can identify biologically aggressive and highly malignant tumors and that it can predict the prognosis of patients with ovarian cancer."
Subscribe to:
Posts
(
Atom
)
